Thomas Frogne
Impact in
-
- HER2/EGFR in Cancer Research
-
- Hippo pathway signaling and YAP/TAZ
Papers in
- Genetics 5
- Diabetes and associated disorders 2
- Estrogen and related hormone effects 2
- Co-authors
- Anne E. Lykkesfeldt (6 shared papers)Anne‐Vibeke Lænkholm (2 shared papers)Jan Stenvang (2 shared papers)Rikke Vicki Benjaminsen (2 shared papers)François N. Pattou (1 shared paper)Zahra Azizi (1 shared paper)Federico Paroni (1 shared paper)Ting Yuan (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (2 papers)Cancer Letters (1 paper)Nature Medicine (1 paper)Journal of Clinical Investigation (1 paper)BMC Molecular Biology (1 paper)
- Partner nations
- DenmarkFranceUnited States
In The Last Decade
Thomas Frogne
11 papers receiving 570 citations
Peers
Comparison fields: 5 of 62
- Oncology 181
- Cell Biology 89
- Genetics 143
- Molecular Biology 270
- Cancer Research 49
Countries citing papers authored by Thomas Frogne
This map shows the geographic impact of Thomas Frogne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Frogne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Frogne more than expected).
Fields of papers citing papers by Thomas Frogne
This network shows the impact of papers produced by Thomas Frogne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Frogne. The network helps show where Thomas Frogne may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Frogne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 174 | |
| 2 | 2008 | 134 | |
| 3 | 2005 | 76 | |
| 4 | 2009 | 67 | |
| 5 | 2007 | 44 | |
| 6 | 2009 | 28 | |
| 7 | 2021 | 18 | |
| 8 | 2012 | 16 | |
| 9 | 2016 | 12 | |
| 10 | 2015 | 6 | |
| 11 | 2008 | 3 |
About Thomas Frogne
Thomas Frogne is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism, Surgery, Oncology and Molecular Biology, having authored 11 papers that have together received 578 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (3 papers), Diabetes and associated disorders (2 papers), Estrogen and related hormone effects (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), HER2/EGFR in Cancer Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Xenotransplantation and immune response (1 paper). The work is most often cited by research in Oncology (181 citations), Cell Biology (89 citations), Genetics (143 citations), Molecular Biology (270 citations) and Cancer Research (49 citations). Thomas Frogne has collaborated with scholars based in Denmark, France and United States. Frequent co-authors include Anne E. Lykkesfeldt, Anne‐Vibeke Lænkholm, Jan Stenvang, Rikke Vicki Benjaminsen, François N. Pattou, Zahra Azizi, Federico Paroni, Ting Yuan, Julie Kerr-Conte and Kathrin Maedler. Their work appears in journals such as Breast Cancer Research and Treatment, Cancer Letters, Nature Medicine, Journal of Clinical Investigation and BMC Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.